Nephron Sparing Surgery is a Feasible and Efficient Treatment of T1a Renal Cell Carcinoma in Kidney Transplant: A Prospective Series From a Single Center

Journal of Urology

Volumn 180, Issue 5, 2008, Pages 2106-2109

  Chambade, D ^a   Meria, P ^a   Tariel, E ^a   Verine J ^a   De Kerviler, E ^a   Peraldi, M N ^a   Glotz, D ^a   Desgrandchamps, F ^a   Mongiat Artus, P ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

carcinoma, renal cell; kidney transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ARTICLE; BLEEDING; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CARCINOMA; KIDNEY FUNCTION; KIDNEY GRAFT; MAJOR CLINICAL STUDY; NEPHRON SPARING SURGERY; OPERATION DURATION; PRIORITY JOURNAL; RECIPIENT; RENAL GRAFT DYSFUNCTION; TREATMENT OUTCOME;

ADULT; BIOPSY, NEEDLE; CARCINOMA, RENAL CELL; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM STAGING; NEPHRECTOMY; NEPHRONS; PROSPECTIVE STUDIES; REOPERATION; RISK ASSESSMENT; SURVIVAL RATE; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 53249109333     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.07.055     Document Type: Article

References (17)

1. Webster A.C., Craig J.C., Simpson J.M., Jones M.P., and Chapman J.R. Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients. Am J Transplant 7 (2007) 2140
2. Penn I. Primary kidney tumors before and after renal transplantation. Transplantation 59 (1995) 480
3. Barama A., St-Louis G., Nicolet V., Hadjeres R., and Daloze P. Renal cell carcinoma in kidney allografts: a case series from a single center. Am J Transplant 5 (2005) 3015
4. Rao P.S., Schaubel D.E., Jia X., Li S., Port F.K., and Saran R. Survival on dialysis post-kidney transplant failure: results from the Scientific Registry of Transplant Recipients. Am J Kidney Dis 49 (2007) 294
5. Ljungberg B., Hanbury D.C., Kuczyk M.A., Merseburger A.S., Mulders P.F., Patard J.J., et al. Renal cell carcinoma guideline. Eur Urol 51 (2007) 1502
6. Lutz J., and Heemann U. Tumours after kidney transplantation. Curr Opin Urol 13 (2003) 105
7. Vajdic C.M., McDonald S.P., McCredie M.R., van Leeuwen M.T., Stewart J.H., Law M., et al. Cancer incidence before and after kidney transplantation. JAMA 296 (2006) 2823
8. Moudouni S.M., Lakmichi A., Tligui M., Rafii A., Tchala K., Haab F., et al. Renal cell carcinoma of native kidney in renal transplant recipients. BJU Int 98 (2006) 298
9. Neuzillet Y., Lechevallier E., Andre M., Daniel L., and Coulange C. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol 171 (2004) 1802
10. Neuzillet Y., Lechevallier E., Andre M., Daniel L., Nahon O., and Coulange C. Follow-up of renal oncocytoma diagnosed by percutaneous tumor biopsy. Urology 66 (2005) 1181
11. Tickoo S.K., DePeralta-Venturina M.N., Harik L.R., Worcester H.D., Salama M.E., Young A.N., et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30 (2006) 141
12. Mejean A., Hopirtean V., Bazin J.P., Larousserie F., Benoit H., Chretien Y., et al. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality?. J Urol 170 (2003) 764
13. Roy C., El Ghali S., Buy X., Lindner V., and Gani A. Papillary renal cell carcinoma in allograft kidney. Eur Radiol 15 (2005) 661
14. Baughman S.M., Sexton W.J., Glaton C.W., Dalrymple N.C., and Bishoff J.T. Computerized tomography guided radio frequency ablation of a renal cell carcinoma within a renal allograft. J Urol 172 (2004) 1262
15. Hruby G.W., Fine J.K., and Landman J. Ultrasound-guided percutaneous ablation of a renal mass in a renal allograft. Urology 68 (2006) 819
16. Kauffman H.M., Cherikh W.S., Cheng Y., Hanto D.W., and Kahan B.D. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with reduced incidence of de novo malignancies. Transplantation 80 (2005) 883
17. Hudes G., Carducci M., Tomczak P., Dutcher J., Figlin R., Kapoor A., et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 356 (2007) 2271